|
Re: Precedence in Gene Therapy Pricing
|
6
|
Resverlogix Corp.
|
Jan 03, 2018 12:40PM
|
|
Re: Too good "to be allowed" to be true?
|
5
|
Resverlogix Corp.
|
Dec 31, 2017 04:55AM
|
|
Re: Nice price rise
|
3
|
Resverlogix Corp.
|
Dec 29, 2017 03:58PM
|
|
Re: Finance
|
2
|
Resverlogix Corp.
|
Dec 29, 2017 12:36PM
|
|
Merry Christmas
|
4
|
Resverlogix Corp.
|
Dec 23, 2017 05:12PM
|
|
Re: Travel Point of Interest
|
2
|
Resverlogix Corp.
|
Dec 22, 2017 02:52PM
|
|
Re: NOL carry forward may be one reason Eastern did not renew loan
|
1
|
Resverlogix Corp.
|
Dec 22, 2017 09:09AM
|
|
NOL carry forward may be one reason Eastern did not renew loan
|
1
|
Resverlogix Corp.
|
Dec 22, 2017 04:02AM
|
|
Re: US 2017 Tax Cuts and Jobs Act
|
2
|
Resverlogix Corp.
|
Dec 21, 2017 08:52PM
|
|
Re: Here's what I'd like to see - a 1:5 Reverse coupled with a listing on the Naz
|
5
|
Resverlogix Corp.
|
Dec 20, 2017 10:45AM
|
|
Re: Here's what I'd like to see - a 1:5 Reverse coupled with a listing on the Naz
|
5
|
Resverlogix Corp.
|
Dec 20, 2017 10:37AM
|
|
Re: Here's what I'd like to see - a 1:5 Reverse coupled with a listing on the Naz
|
5
|
Resverlogix Corp.
|
Dec 20, 2017 01:55AM
|
|
Re: Zenith AGM - Q&A
|
3
|
Zenith Epigenetics
|
Dec 19, 2017 04:21PM
|
|
Zenith AGM - Q&A
|
7
|
Zenith Epigenetics
|
Dec 19, 2017 02:06AM
|
|
Re: RVX AGM 12 Dec 2017 meeting note, Q&A and comments
|
3
|
Resverlogix Corp.
|
Dec 18, 2017 04:16PM
|
|
$300 Billion Life of Patent Sales Caution is Required
|
4
|
Resverlogix Corp.
|
Dec 18, 2017 01:37PM
|
|
Re: RVX AGM 12 Dec 2017 meeting note, Q&A and comments
|
2
|
Resverlogix Corp.
|
Dec 18, 2017 01:11PM
|
|
Re: RVX AGM 12 Dec 2017 meeting note, Q&A and comments
|
4
|
Resverlogix Corp.
|
Dec 18, 2017 10:55AM
|
|
Re: RVX AGM 12 Dec 2017 meeting note, Q&A and comments
|
4
|
Resverlogix Corp.
|
Dec 18, 2017 10:09AM
|
|
RVX AGM 12 Dec 2017 meeting note, Q&A and comments
|
15
|
Resverlogix Corp.
|
Dec 18, 2017 05:47AM
|
